Bibliographic Details
| Title: |
Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies |
| Authors: |
Roger H. Kobayashi, Sudhir Gupta, Isaac Melamed, J. Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, Thomas Prescott Atkinson, Syed Rehman, Eva Turpel-Kantor, Jiří Litzman |
| Source: |
Frontiers in Immunology, Vol 13 (2022) |
| Publisher Information: |
Frontiers Media S.A., 2022. |
| Publication Year: |
2022 |
| Collection: |
LCC:Immunologic diseases. Allergy |
| Subject Terms: |
primary immunodeficiencies, immunoglobulins, antibodies, SCIG, infections, infusion site reactions, Immunologic diseases. Allergy, RC581-607 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1664-3224 |
| Relation: |
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1110388/full; https://doaj.org/toc/1664-3224 |
| DOI: |
10.3389/fimmu.2022.1110388 |
| Access URL: |
https://doaj.org/article/40b30801152944dcaa8a5c8a21430349 |
| Accession Number: |
edsdoj.40b30801152944dcaa8a5c8a21430349 |
| Database: |
Directory of Open Access Journals |
